CPRX News and Press, Catalyst Pharmaceuticals Inc. From 01/06/20

Shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) were jumping 13.7% higher as of 3:01 p.m. EST on Monday. Investors reacted positively after Catalyst provided a corporate update earlier in the day that included a sneak peek at full-year 2019 net revenue for lead drug Firdapse and guidance f...

Catalyst Pharmaceuticals ( CPRX +5.4% ) is up on below-average volume on the heels of its preliminary 2019 results and 2020 guidance. More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

- Firdapse 2019 Net Product Revenues Expected to be Approximately $102 Million - Anticipates Full Year 2020 Firdapse Net Product Revenues to be in the Range of $135 million to $155 million - MuSK-MG Clinical Trial Has Met Enrollment Goals and is on Schedule to Report Top-Li...

The FDA Breakthrough Therapy Designation (BTD) was an offshoot of the Food and Drug Administration Safety and Innovation Act (FDASIA) that was signed on July 9, 2012 , that called for a new designation to be created. Since 2012, only 147 drugs have been approved having this designation, which...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on multiple discriminant analysis ((MDA)) breakout selections over more than five years. This subset of the different portfolios I regularly analyze has now reached 135 weeks of public selections as part of t...

General Background Founded in 2002, Catalyst Pharmaceuticals ( CPRX ) specializes in obtaining treatments for rare diseases, many of which have no FDA-approved treatment options. Much of this article focuses on the current status of the company, with particular emphasis on the many catalysts...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 134 weeks of public selections as part of this ongoing live forward-testing. In...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch t...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

CORAL GABLES, Fla., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurologic...